Skip to main content
Erschienen in: Familial Cancer 3/2012

01.09.2012 | Original Article

Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations

verfasst von: Monique A. de Bruin, Ava Kwong, Benjamin A. Goldstein, Jafi A. Lipson, Debra M. Ikeda, Lisa McPherson, Bhavna Sharma, Ani Kardashian, Elizabeth Schackmann, Kerry E. Kingham, Meredith A. Mills, Dee W. West, James M. Ford, Allison W. Kurian

Erschienen in: Familial Cancer | Ausgabe 3/2012

Einloggen, um Zugang zu erhalten

Abstract

The prevalence and penetrance of BRCA1 and BRCA2 (BRCA1/2) mutations may differ between Asians and whites. We investigated BRCA1/2 mutations and cancer risk factors in a clinic-based sample. BRCA1/2 mutation carriers were enrolled from cancer genetics clinics in Hong Kong and California according to standardized entry criteria. We compared BRCA mutation position, cancer history, hormonal and reproductive exposures. We analyzed DNA samples for single-nucleotide polymorphisms reported to modify breast cancer risk. We performed logistic regression to identify independent predictors of breast cancer. Fifty Asian women and forty-nine white American women were enrolled. BRCA1 mutations were more common among whites (67 vs. 42 %, p = 0.02), and BRCA2 mutations among Asians (58 vs. 37 %, p = 0.04). More Asians had breast cancer (76 vs. 53 %, p = 0.03); more whites had relatives with breast cancer (86 vs. 50 %, p = 0.0003). More whites than Asians had breastfed (71 vs. 42 %, p = 0.005), had high BMI (median 24.3 vs. 21.2, p = 0.04), consumed alcohol (2 drinks/week vs. 0, p < 0.001), and had oophorectomy (61 vs. 34 %, p = 0.01). Asians had a higher frequency of risk-associated alleles in MAP3K1 (88 vs. 59 %, p = 0.005) and TOX3/TNRC9 (88 vs. 55 %, p = 0.0002). On logistic regression, MAP3K1 was associated with increased breast cancer risk for BRCA2, but not BRCA1 mutation carriers; breast density was associated with increased risk among Asians but not whites. We found significant differences in breast cancer risk factors between Asian and white BRCA1/2 mutation carriers. Further investigation of racial differences in BRCA1/2 mutation epidemiology could inform targeted cancer risk-reduction strategies.
Literatur
1.
Zurück zum Zitat Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, vol VII. IARC, Lyon Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, vol VII. IARC, Lyon
2.
Zurück zum Zitat Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155–160PubMedCrossRef Son BH, Kwak BS, Kim JK et al (2006) Changing patterns in the clinical characteristics of Korean patients with breast cancer during the last 15 years. Arch Surg 141:155–160PubMedCrossRef
3.
Zurück zum Zitat Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250PubMedCrossRef Yang L, Parkin DM, Ferlay J, Li L, Chen Y (2005) Estimates of cancer incidence in China for 2000 and projections for 2005. Cancer Epidemiol Biomarkers Prev 14:243–250PubMedCrossRef
4.
Zurück zum Zitat Yang L, Parkin DM, Li L, Chen Y (2003) Time trends in cancer mortality in China: 1987–1999. Int J Cancer 106(5):771–783PubMedCrossRef Yang L, Parkin DM, Li L, Chen Y (2003) Time trends in cancer mortality in China: 1987–1999. Int J Cancer 106(5):771–783PubMedCrossRef
5.
Zurück zum Zitat Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer 90(11):2157–2166PubMed Yang L, Parkin DM, Li LD, Chen YD, Bray F (2004) Estimation and projection of the national profile of cancer mortality in China: 1991–2005. Br J Cancer 90(11):2157–2166PubMed
6.
Zurück zum Zitat Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479–1483PubMed Buell P (1973) Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst 51:1479–1483PubMed
7.
Zurück zum Zitat LeMarchand L, Kolonel LN, Nomura AM (1985) Breast cancer survival among Hawaii Japanese and Caucasian women. Ten-year rates and survival by place of birth. Am J Epidemiol 122:571–578PubMed LeMarchand L, Kolonel LN, Nomura AM (1985) Breast cancer survival among Hawaii Japanese and Caucasian women. Ten-year rates and survival by place of birth. Am J Epidemiol 122:571–578PubMed
8.
Zurück zum Zitat Meng L, Maskarinec G, Wilkens L (1997) Ethnic differences and factors related to breast cancer survival in Hawaii. Int J Epidemiol 26:1151–1158PubMedCrossRef Meng L, Maskarinec G, Wilkens L (1997) Ethnic differences and factors related to breast cancer survival in Hawaii. Int J Epidemiol 26:1151–1158PubMedCrossRef
9.
Zurück zum Zitat Ward-Hinds M, Kolonel LN, Nomura AM, Lee J (1982) Stage-specific breast-cancer incidence rates by age among Japanese and Caucasian women in Hawaii, 1960–1979. Br J Cancer 45:118–123PubMedCrossRef Ward-Hinds M, Kolonel LN, Nomura AM, Lee J (1982) Stage-specific breast-cancer incidence rates by age among Japanese and Caucasian women in Hawaii, 1960–1979. Br J Cancer 45:118–123PubMedCrossRef
10.
Zurück zum Zitat Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48:1949–1953PubMed Yuan JM, Yu MC, Ross RK, Gao YT, Henderson BE (1988) Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 48:1949–1953PubMed
11.
Zurück zum Zitat Ziegler RG, Hoover RN, Pike MC et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827PubMedCrossRef Ziegler RG, Hoover RN, Pike MC et al (1993) Migration patterns and breast cancer risk in Asian-American women. J Natl Cancer Inst 85:1819–1827PubMedCrossRef
12.
Zurück zum Zitat Pike MC, Kolonel LN, Henderson BE et al (2002) Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 11:795–800PubMed Pike MC, Kolonel LN, Henderson BE et al (2002) Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev 11:795–800PubMed
13.
Zurück zum Zitat Kurian AW, Fish K, Shema SJ, Clarke CA (2010) Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res 12:R99PubMedCrossRef Kurian AW, Fish K, Shema SJ, Clarke CA (2010) Lifetime risks of specific breast cancer subtypes among women in four racial/ethnic groups. Breast Cancer Res 12:R99PubMedCrossRef
14.
Zurück zum Zitat Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297–8308PubMedCrossRef Malone KE, Daling JR, Doody DR et al (2006) Prevalence and predictors of BRCA1 and BRCA2 mutations in a population-based study of breast cancer in white and black American women ages 35 to 64 years. Cancer Res 66:8297–8308PubMedCrossRef
15.
Zurück zum Zitat John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, West DW, Whittemore AS (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869–2876PubMedCrossRef John EM, Miron A, Gong G, Phipps AI, Felberg A, Li FP, West DW, Whittemore AS (2007) Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups. JAMA 298:2869–2876PubMedCrossRef
16.
Zurück zum Zitat Begg CB, Haile RW, Borg A et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299:194–201PubMedCrossRef Begg CB, Haile RW, Borg A et al (2008) Variation of breast cancer risk among BRCA1/2 carriers. JAMA 299:194–201PubMedCrossRef
17.
Zurück zum Zitat Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333PubMedCrossRef Chen S, Parmigiani G (2007) Meta-analysis of BRCA1 and BRCA2 penetrance. J Clin Oncol 25:1329–1333PubMedCrossRef
18.
Zurück zum Zitat Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 26:4752–4758PubMedCrossRef Kurian AW, Gong GD, Chun NM et al (2008) Performance of BRCA1/2 mutation prediction models in Asian Americans. J Clin Oncol 26:4752–4758PubMedCrossRef
19.
Zurück zum Zitat Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104PubMedCrossRef Chenevix-Trench G, Milne RL, Antoniou AC, Couch FJ, Easton DF, Goldgar DE (2007) An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA). Breast Cancer Res 9:104PubMedCrossRef
20.
Zurück zum Zitat Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCrossRef Antoniou A, Pharoah PD, Narod S et al (2003) Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. Am J Hum Genet 72:1117–1130PubMedCrossRef
21.
Zurück zum Zitat Milne RL, Antoniou AC (2011) Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol 22(Suppl 1):i11–i17PubMedCrossRef Milne RL, Antoniou AC (2011) Genetic modifiers of cancer risk for BRCA1 and BRCA2 mutation carriers. Ann Oncol 22(Suppl 1):i11–i17PubMedCrossRef
22.
Zurück zum Zitat Antoniou AC, Beesley J, McGuffog L et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70:9742–9754PubMedCrossRef Antoniou AC, Beesley J, McGuffog L et al (2010) Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. Cancer Res 70:9742–9754PubMedCrossRef
23.
Zurück zum Zitat Bergqvist J, Latif A, Roberts SA et al (2010) RASSF1A polymorphism in familial breast cancer. Fam Cancer 9:263–265PubMedCrossRef Bergqvist J, Latif A, Roberts SA et al (2010) RASSF1A polymorphism in familial breast cancer. Fam Cancer 9:263–265PubMedCrossRef
25.
Zurück zum Zitat Kwong A, Wong LP, Wong HN, Law FDF et al (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3(1–4):63–76PubMedCrossRef Kwong A, Wong LP, Wong HN, Law FDF et al (2009) Clinical and pathological characteristics of Chinese patients with BRCA related breast cancer. Hugo J 3(1–4):63–76PubMedCrossRef
26.
Zurück zum Zitat Daly MB, Axilbund JE, Buys S et al (2010) Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8:562–594PubMed Daly MB, Axilbund JE, Buys S et al (2010) Genetic/familial high-risk assessment: breast and ovarian. J Natl Compr Canc Netw 8:562–594PubMed
27.
Zurück zum Zitat Boyd N, Martin L, Gunasekara A et al (2009) Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev 18:1754–1762PubMedCrossRef Boyd N, Martin L, Gunasekara A et al (2009) Mammographic density and breast cancer risk: evaluation of a novel method of measuring breast tissue volumes. Cancer Epidemiol Biomarkers Prev 18:1754–1762PubMedCrossRef
28.
Zurück zum Zitat Boyd NF, Martin LJ, Rommens JM et al (2009) Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 472:343–360PubMedCrossRef Boyd NF, Martin LJ, Rommens JM et al (2009) Mammographic density: a heritable risk factor for breast cancer. Methods Mol Biol 472:343–360PubMedCrossRef
29.
Zurück zum Zitat Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. 7th Printing, Springer, Chicago, IL pp 347–76 Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A (2010) AJCC cancer staging manual. 7th Printing, Springer, Chicago, IL pp 347–76
30.
Zurück zum Zitat Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093PubMedCrossRef Easton DF, Pooley KA, Dunning AM et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087–1093PubMedCrossRef
31.
Zurück zum Zitat Antoniou AC, Spurdle AB, Sinilnikova OM et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82:937–948PubMedCrossRef Antoniou AC, Spurdle AB, Sinilnikova OM et al (2008) Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. Am J Hum Genet 82:937–948PubMedCrossRef
32.
Zurück zum Zitat Gao B, Xie XJ, Huang C et al (2008) RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 68:22–25PubMedCrossRef Gao B, Xie XJ, Huang C et al (2008) RASSF1A polymorphism A133S is associated with early onset breast cancer in BRCA1/2 mutation carriers. Cancer Res 68:22–25PubMedCrossRef
33.
Zurück zum Zitat Mulligan AM, Couch FJ, Barrowdale D et al (2011) Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2. Breast Cancer Res 13:R110PubMedCrossRef Mulligan AM, Couch FJ, Barrowdale D et al (2011) Common breast cancer susceptibility alleles are associated with tumor subtypes in BRCA1 and BRCA2 mutation carriers: results from the consortium of investigators of modifiers of BRCA1/2. Breast Cancer Res 13:R110PubMedCrossRef
34.
Zurück zum Zitat Kolonel LN, Altshuler D, Henderson BE (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4:519–527PubMedCrossRef Kolonel LN, Altshuler D, Henderson BE (2004) The multiethnic cohort study: exploring genes, lifestyle and cancer risk. Nat Rev Cancer 4:519–527PubMedCrossRef
35.
Zurück zum Zitat Maskarinec G, Noh JJ (2004) The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 14:431–439PubMed Maskarinec G, Noh JJ (2004) The effect of migration on cancer incidence among Japanese in Hawaii. Ethn Dis 14:431–439PubMed
36.
Zurück zum Zitat Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 carrier cohort study (IBCCS). J Natl Cancer Inst 98:535–544PubMedCrossRef Andrieu N, Goldgar DE, Easton DF et al (2006) Pregnancies, breast-feeding, and breast cancer risk in the International BRCA1/2 carrier cohort study (IBCCS). J Natl Cancer Inst 98:535–544PubMedCrossRef
37.
Zurück zum Zitat Antoniou AC, Shenton A, Maher ER et al (2006) Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 8:R72PubMedCrossRef Antoniou AC, Shenton A, Maher ER et al (2006) Parity and breast cancer risk among BRCA1 and BRCA2 mutation carriers. Breast Cancer Res 8:R72PubMedCrossRef
38.
Zurück zum Zitat Moorman PG, Iversen ES, Marcom PK et al (2010) Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat 124:441–451PubMedCrossRef Moorman PG, Iversen ES, Marcom PK et al (2010) Evaluation of established breast cancer risk factors as modifiers of BRCA1 or BRCA2: a multi-center case-only analysis. Breast Cancer Res Treat 124:441–451PubMedCrossRef
39.
Zurück zum Zitat Dennis J, Ghadirian P, Little J et al (2010) Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. Breast 19:479–483PubMedCrossRef Dennis J, Ghadirian P, Little J et al (2010) Alcohol consumption and the risk of breast cancer among BRCA1 and BRCA2 mutation carriers. Breast 19:479–483PubMedCrossRef
40.
Zurück zum Zitat McGuire V, John EM, Felberg A et al (2006) No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. Cancer Epidemiol Biomarkers Prev 15:1565–1567PubMedCrossRef McGuire V, John EM, Felberg A et al (2006) No increased risk of breast cancer associated with alcohol consumption among carriers of BRCA1 and BRCA2 mutations ages < 50 years. Cancer Epidemiol Biomarkers Prev 15:1565–1567PubMedCrossRef
41.
Zurück zum Zitat Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306:1884–1890PubMedCrossRef Chen WY, Rosner B, Hankinson SE, Colditz GA, Willett WC (2011) Moderate alcohol consumption during adult life, drinking patterns, and breast cancer risk. JAMA 306:1884–1890PubMedCrossRef
42.
Zurück zum Zitat Wong CS, Lim GH, Gao F et al (2011) Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 104:871–874PubMedCrossRef Wong CS, Lim GH, Gao F et al (2011) Mammographic density and its interaction with other breast cancer risk factors in an Asian population. Br J Cancer 104:871–874PubMedCrossRef
43.
Zurück zum Zitat Mitchell G, Antoniou AC, Warren R et al (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66:1866–1872PubMedCrossRef Mitchell G, Antoniou AC, Warren R et al (2006) Mammographic density and breast cancer risk in BRCA1 and BRCA2 mutation carriers. Cancer Res 66:1866–1872PubMedCrossRef
44.
Zurück zum Zitat Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975PubMedCrossRef Domchek SM, Friebel TM, Singer CF et al (2010) Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality. JAMA 304(9):967–975PubMedCrossRef
45.
Zurück zum Zitat Kwong A, Wong CH, Shea C, Suen DT, Choi CL (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416–1426PubMedCrossRef Kwong A, Wong CH, Shea C, Suen DT, Choi CL (2010) Choice of management of southern Chinese BRCA mutation carriers. World J Surg 34:1416–1426PubMedCrossRef
46.
Zurück zum Zitat Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222–2233PubMedCrossRef Hall MJ, Reid JE, Burbidge LA et al (2009) BRCA1 and BRCA2 mutations in women of different ethnicities undergoing testing for hereditary breast-ovarian cancer. Cancer 115(10):2222–2233PubMedCrossRef
47.
Zurück zum Zitat Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706PubMedCrossRef Risch HA, McLaughlin JR, Cole DE et al (2006) Population BRCA1 and BRCA2 mutation frequencies and cancer penetrances: a kin-cohort study in Ontario, Canada. J Natl Cancer Inst 98:1694–1706PubMedCrossRef
48.
Zurück zum Zitat Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282–4288PubMedCrossRef Atchley DP, Albarracin CT, Lopez A et al (2008) Clinical and pathologic characteristics of patients with BRCA-positive and BRCA-negative breast cancer. J Clin Oncol 26:4282–4288PubMedCrossRef
49.
Zurück zum Zitat Telli ML, Chang ET, Kurian AW et al (2010) Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat 127:471–478PubMedCrossRef Telli ML, Chang ET, Kurian AW et al (2010) Asian ethnicity and breast cancer subtypes: a study from the California Cancer Registry. Breast Cancer Res Treat 127:471–478PubMedCrossRef
50.
Zurück zum Zitat Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH (2011) Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer 10:199–205PubMedCrossRef Yoon SY, Thong MK, Taib NA, Yip CH, Teo SH (2011) Genetic counseling for patients and families with hereditary breast and ovarian cancer in a developing Asian country: an observational descriptive study. Fam Cancer 10:199–205PubMedCrossRef
51.
Zurück zum Zitat Chin TM, Tan SH, Lim SE, Iau P, Yong WP, Wong SW, Lee SC (2005) Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians. Cancer Detect Prev 29:412–418PubMedCrossRef Chin TM, Tan SH, Lim SE, Iau P, Yong WP, Wong SW, Lee SC (2005) Acceptance, motivators, and barriers in attending breast cancer genetic counseling in Asians. Cancer Detect Prev 29:412–418PubMedCrossRef
52.
Zurück zum Zitat Zhang WJ, Gao YJ, Li QB, Xu D (2006) Breast cancer in China: demand for genetic counseling and genetic testing. Genet Med 8(3):196–197PubMedCrossRef Zhang WJ, Gao YJ, Li QB, Xu D (2006) Breast cancer in China: demand for genetic counseling and genetic testing. Genet Med 8(3):196–197PubMedCrossRef
53.
Zurück zum Zitat Rao NY, Hu Z, Li WF et al (2008) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467–477PubMedCrossRef Rao NY, Hu Z, Li WF et al (2008) Models for predicting BRCA1 and BRCA2 mutations in Han Chinese familial breast and/or ovarian cancer patients. Breast Cancer Res Treat 113:467–477PubMedCrossRef
54.
Zurück zum Zitat Lowe HJ, Ferris TA, Hernandez PM, Weber SC (2009) STRIDE–An integrated standards-based translational research informatics platform. AMIA Annu Symp Proc 2009:391–395PubMed Lowe HJ, Ferris TA, Hernandez PM, Weber SC (2009) STRIDE–An integrated standards-based translational research informatics platform. AMIA Annu Symp Proc 2009:391–395PubMed
Metadaten
Titel
Breast cancer risk factors differ between Asian and white women with BRCA1/2 mutations
verfasst von
Monique A. de Bruin
Ava Kwong
Benjamin A. Goldstein
Jafi A. Lipson
Debra M. Ikeda
Lisa McPherson
Bhavna Sharma
Ani Kardashian
Elizabeth Schackmann
Kerry E. Kingham
Meredith A. Mills
Dee W. West
James M. Ford
Allison W. Kurian
Publikationsdatum
01.09.2012
Verlag
Springer Netherlands
Erschienen in
Familial Cancer / Ausgabe 3/2012
Print ISSN: 1389-9600
Elektronische ISSN: 1573-7292
DOI
https://doi.org/10.1007/s10689-012-9531-9

Weitere Artikel der Ausgabe 3/2012

Familial Cancer 3/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.